Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuko Masutani

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Medicines (Basel, Switzerland)|August 6, 2021
A Combination of GM-CSF and Released Factors from Gamma-Irradiated Tumor Cells Enhances the Differentiation of Macrophages from Bone Marrow Cells and Their Antigen-Presenting Function and Polarization to Type 1Lichao Chen, Shoji Imamichi, Ying Tong, et al.
Journal of Cell Science|July 23, 2013
Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose)Leizhen Wei, Satoshi Nakajima, Ching-Lung Hsieh, et al.
International Journal of Molecular Sciences|October 23, 2015
PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling PathwayYuta Kishi, Hisako Fujihara, Koji Kawaguchi, et al.
Cancer Letters|November 30, 2016
Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cellsJinhua Piao, Shiori Takai, Takahiro Kamiya, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 3, 2014
Histological and biochemical analysis of DNA damage after BNCT in rat modelMitsuko Masutani, Diaz Baiseitov, Tasuku Itoh, et al.
International Journal of Molecular Sciences|March 2, 2016
Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in VivoMasaaki Yasukawa, Hisako Fujihara, Hiroaki Fujimori, et al.
Nucleic Acids Research|July 19, 2014
ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cellsStephen J Roper, Stephanie Chrysanthou, Claire E Senner, et al.
Cancer Letters|December 13, 2005
Parp-1 deficiency does not increase the frequency of tumors in the oral cavity and esophagus of ICR/129Sv mice by 4-nitroquinoline 1-oxide, a carcinogen producing bulky adductsAkemi Gunji, Akiko Uemura, Masahiro Tsutsumi, et al.
Cancer Research|May 31, 2019
Dysfunction of Poly (ADP-Ribose) Glycohydrolase Induces a Synthetic Lethal Effect in Dual Specificity Phosphatase 22-Deficient Lung Cancer CellsYuka Sasaki, Hiroaki Fujimori, Miyuki Hozumi, et al.
BMC Genomics|February 9, 2007
Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cellsHideki Ogino, Tadashige Nozaki, Akemi Gunji, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Medicines (Basel, Switzerland)|August 6, 2021
A Combination of GM-CSF and Released Factors from Gamma-Irradiated Tumor Cells Enhances the Differentiation of Macrophages from Bone Marrow Cells and Their Antigen-Presenting Function and Polarization to Type 1Lichao Chen, Shoji Imamichi, Ying Tong, et al.
Journal of Cell Science|July 23, 2013
Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose)Leizhen Wei, Satoshi Nakajima, Ching-Lung Hsieh, et al.
International Journal of Molecular Sciences|October 23, 2015
PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling PathwayYuta Kishi, Hisako Fujihara, Koji Kawaguchi, et al.
Cancer Letters|November 30, 2016
Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cellsJinhua Piao, Shiori Takai, Takahiro Kamiya, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 3, 2014
Histological and biochemical analysis of DNA damage after BNCT in rat modelMitsuko Masutani, Diaz Baiseitov, Tasuku Itoh, et al.
International Journal of Molecular Sciences|March 2, 2016
Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in VivoMasaaki Yasukawa, Hisako Fujihara, Hiroaki Fujimori, et al.
Nucleic Acids Research|July 19, 2014
ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cellsStephen J Roper, Stephanie Chrysanthou, Claire E Senner, et al.
Cancer Letters|December 13, 2005
Parp-1 deficiency does not increase the frequency of tumors in the oral cavity and esophagus of ICR/129Sv mice by 4-nitroquinoline 1-oxide, a carcinogen producing bulky adductsAkemi Gunji, Akiko Uemura, Masahiro Tsutsumi, et al.
Cancer Research|May 31, 2019
Dysfunction of Poly (ADP-Ribose) Glycohydrolase Induces a Synthetic Lethal Effect in Dual Specificity Phosphatase 22-Deficient Lung Cancer CellsYuka Sasaki, Hiroaki Fujimori, Miyuki Hozumi, et al.
BMC Genomics|February 9, 2007
Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cellsHideki Ogino, Tadashige Nozaki, Akemi Gunji, et al.
Pageof 10